Delivery Order SPE2DB22D1017-SPE2DB23FG2YY
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,862,399 units of the pharmaceutical product Chlorthalidone 25 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $2,568.59, with a period of performance through September 19, 2024. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will be providing these essential medication supplies to support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,674.50 contract is for the delivery of Chlorthalidone 25 mg tablets, a cardiovascular medication, to support military and government healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,480.39 contract is for the supply of Chlorthalidone 25 mg tablets to support federal healthcare programs. The award has an ultimate completion date of March 31, 2023 and is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award, with an ID of SPE2DB25D7056|SPE2DB25FTMCP, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,539.77 delivery order contract is for the supply of 4,567,572,950 units of the medication Chlorthalidone 50 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of March 17, 2025. This award is part of a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050.34 firm fixed-price delivery order is for the supply of 1,000 units of the pharmaceutical Chlorthalidone 25 mg tablets, with a performance period through July 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of CHLORTHALIDONE 25 MG TABLET 100S to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a firm fixed-price delivery order awarded on September 2, 2022, with a ceiling value of $5,445.44 and a period of performance through September 6, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,745.11 to AmerisourceBergen Drug Corp for the supply of Chlorthalidone 25 mg tablets in quantities of 1,000 units. This contract, awarded on July 30, 2025, with a completion date of July 31, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- This federal contract award is for the delivery of chlorthalidone 25mg tablets, a generic pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, as a firm fixed price delivery order. The contract has a ceiling value of $2,778.31 and a performance period through March 15, 2024. No set-aside designation was used for this contract....
- The Defense Logistics Agency awarded a delivery order valued at $1,240.44 to AmerisourceBergen Drug Corp for the supply of Chlorthalidone 25 mg tablets (100-count units). This competitive award, issued on July 28, 2025, represents a firm fixed price delivery order with an ultimate completion date of July 29, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- This federal contract award is for the delivery of hydrochlorothiazide 25 mg tablets in quantities of 500 per order. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB23FG2YYDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under the Defense Logistics Agency's (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999. The contract is for the delivery of 4,562,259,626 units of the drug Chlorthalidone 25 mg tablets to support military healthcare programs. The award has a 1-year period of performance ending on September 8, 2023, with a ceiling value of $20,184.05. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA, enabling efficient procurement of essential healthcare commodities for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.2k | 9/7/23 |